Armin Reininger

At Swedish Orphan Biovitrum AB (publ), listed in Stockholm, Armin Reininger sold EUR 5,338,994 in 8 sales (median EUR 386,567) and bought EUR 3,138,960 in 3 purchases (median EUR 1,074,248), so purchases are 27% of the market trades. The declared status is Annan ledande befattningshavare (other senior executive).

The three largest sales and the three purchases line up by date: a sale of EUR 1,035,125 on June 8, 2022, then a purchase of EUR 863,571 on June 10, 2022; a sale of EUR 1,384,085 on November 10, 2023, then a purchase of EUR 1,201,140 on November 14, 2023; a sale of EUR 2,064,731 on June 4, 2024, then a purchase of EUR 1,074,248 on June 7, 2024.

The 19 filings run from May 28, 2020 to August 29, 2024, with 5 in 2022, 6 in 2023 and 4 in 2024. They also include 7 share grants and one filing of another kind. Filings are published a median of 3 days after the trade. None falls in the last twelve months.

5, 4 and 3 trades by Reininger fall within 30 days of colleagues at Swedish Orphan Biovitrum AB (publ), in that order. In the same direction: 4, 3 and 3. In the same order, the colleagues are Mahmood Ladha, Guido Oelkers and Daniel Rankin.